Annual report [Section 13 and 15(d), not S-K Item 405]

Note purchase agreement and consulting agreement with G FarmaLabs Limited (Details Narrative)

Note purchase agreement and consulting agreement with G FarmaLabs Limited (Details Narrative) - USD ($)					1 Months Ended	12 Months Ended
	Jul. 11, 2023	Aug. 27, 2021	Mar. 04, 2019	Mar. 17, 2017	Oct. 31, 2022	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2022	Aug. 31, 2022	Nov. 04, 2020	Apr. 24, 2019
G Farma Settlors [Member]
Litigation settlement amount awarded from other party	$ 2,539,597					$ 2,539,597
Litigation settlement default amount	2,494,450
Interest receivable	40,219					375,025
Litigation settlement costs	1,643
Attorneys fee	$ 3,285
Debt instrument, interest rate, effective percentage	10.00%
Two promissory notes [Member]
Principal amount										$ 1,166,570
G FarmaLabs Limited [Member]
Cost of impounded assets											$ 427,804
Notes receivable bad debt reserve						1,039,501	$ 1,039,501
Notes receivable related party						0	0
Other income						$ 0	$ 0
G FarmaLabs Limited [Member] \| Mentor partner I [Member]
Cost of impounded assets											$ 427,804
Notes purchase agreement [Member] \| G FarmaLabs Limited [Member]
Principal amount			$ 990,000	$ 500,000
Debt instrument, interest rate, stated percentage				7.42%
Debt instrument, maturity date				Apr. 15, 2022
Debt instrument, periodic payment			$ 10,239
Settlement agreement and mutual release [Member] \| G Farma Settlors [Member]
Liability for unpaid claims and claims adjustment expense schedule, discussion		The Settlement Agreement required the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest were paid in full. Interest on the unpaid balance initially accrued at the rate of 4.25% per annum, commencing February 25, 2021, compounded monthly, and was to be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%.
Liability for unpaid claims and claims adjustment expense, net		$ 500,000			$ 500,000
Liability for unpaid claims and claims adjustment expense, adjustments		$ 2,000,000			2,000,000			$ 2,000,000	$ 2,000,000
Remaining amount					494,450
Liability for accrued unpaid interest					$ 2,000,000